ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

Novartis at ACR Convergence 2026

Nov 6–11, 2026 Orlando, FL ~15k attendees Website

Novartis brings 11 presentations to ACR Convergence 2026 in Orlando, and exhibits at Booth 3213. Its program centres on real-world evidence across spondyloarthritis, Sjögren's disease, vasculitis and polymyalgia rheumatica. It also covers lupus disease-activity endpoints, a guide to assessing Sjögren's disease, and NLRP3 inhibition in knee osteoarthritis.

OrganizationACR Convergence 2026 Attendance
Novartis
East Hanover, NJ
Pharmaceutical companies
A global medicines company developing and marketing prescription treatments.
Booth
Exhibiting at Booth 3213
Sun, Nov 810:00am–5:00pmMon, Nov 910:00am–5:00pmTue, Nov 1010:00am–2:30pm
Industry
Mon Nov 9
5:30pm–7:30pm
Turning Complexity Into Clinical Clarity: Practical Approaches for the Comprehensive Assessment of Sjögren's Disease
Hyatt Regency Orlando, Windermere Ballroom X
Sjögren’s · with University of Pennsylvania, West Suburban Center for Arthritis

Explore the full ACR Convergence 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Orlando. Leave your work email and we’ll be in touch.

Privacy

Download the full ACR Convergence 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Novartis

Tell us what you sell and we’ll find the people at Novartis most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction